FEBS Letters
Volume 580, Issue 23 , Pages 5442-5449, 9 October 2006

Defects of cholesterol biosynthesis

Edited by Gerrit van Meer

Laboratory Genetic Metabolic Diseases (F0-224), Department of Pediatrics/Emma Children’s Hospital, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands

Received 3 July 2006; accepted 7 July 2006. published online 19 July 2006.

Abstract 

Eight distinct inherited disorders have been linked to different enzyme defects in the isoprenoid/cholesterol biosynthetic pathway following the finding of abnormally increased levels of intermediate metabolites in patients and confirmed by the demonstration of disease-causing mutations in genes encoding the implicated enzymes. Patients afflicted with these disorders are characterized by multiple morphogenic and congenital anomalies including internal organ, skeletal and/or skin abnormalities underlining an important role for cholesterol in human embryogenesis and development. The etiology of the underlying pathophysiology may involve multiple affected processes due to lowered cholesterol and/or the elevated, teratogenic levels of the intermediate sterol precursors.

Keywords: Inborn errors, Isoprenoid, Cholesterol, Embryogenesis, Development

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(06)00868-4

doi:10.1016/j.febslet.2006.07.027

FEBS Letters
Volume 580, Issue 23 , Pages 5442-5449, 9 October 2006